-+ 0.00%
-+ 0.00%
-+ 0.00%

Can D Wave Quantum (QBTS) Still Look Undervalued Following Legal Probes And A CFO Exit?

Simply Wall St·09/18/2026 21:19:15
Listen to the news

D-Wave Quantum (QBTS) is back in focus after several shareholder rights law firms opened investigations into potential securities law violations, following the CFO’s resignation and a revenue miss that raised fresh governance questions.

The latest move puts D-Wave Quantum’s share price at $17.69 after a 1-day share price return of 8.73% and a 7-day share price return of 6.18%, yet the stock remains under pressure with a 30-day share price return down 9.42% and a year-to-date share price return down 37.11%.

That mix of a sharp short-term bounce on the legal and governance headlines, combined with a weaker 90-day share price return down 28.35%, indicates that recent buying interest may be more about recalibrating risk rather than a clear shift in conviction on the long-term story.

For investors looking at the bigger arc, the total shareholder return figures paint a split picture. The 1-year total shareholder return is down 26.35%, while the 3-year total shareholder return is described as very large and the 5-year total shareholder return is up 81.44%. This combination points to earlier enthusiasm now meeting increased scrutiny as legal probes, U.S. government funding and events such as the upcoming Qubits Asia 2026 conference all influence expectations in different directions.

Scan beyond D-Wave Quantum and benchmark this kind of legal and funding risk profile against 25 quantum computing stocks shaping the next phase of quantum computing.

D-Wave Quantum now trades almost 50% below the average analyst target, even after the legal-driven bounce. Is that discount compensation for the risks, or a gap that tighter assumptions will close?

Most Popular Narrative: 50% Undervalued

Against a last close of $17.69, the most followed D-Wave Quantum narrative anchors fair value at $35.24. This frames today’s sharp discount as a test of how much faith you place in aggressive growth translating into future earnings power.

Broadening use of quantum and AI for drug discovery, financial services and telecom optimization, combined with more than 100 revenue generating customers and a strong cash position, may create a platform to compound bookings and narrow adjusted net losses over time.

See why 92 investors see D-Wave Quantum as 50% undervalued.

Result: Fair Value of $35.24 (UNDERVALUED)

Still, the D-Wave Quantum story can break if lumpy system deals dry up, or if rising R&D and go-to-market spending fails to convert backlog into sustainable revenue.

Find out about the key risks to this D-Wave Quantum narrative.

Next Steps

If the split mood around D-Wave Quantum has you on the fence, consider taking action soon. Review the underlying drivers and stress test your own thesis against the 1 key reward and 2 important warning signs.

Looking for more investment ideas beyond D-Wave Quantum?

If D-Wave Quantum has sharpened your focus on risk and reward, broaden your watchlist now by scanning other opportunities that match your return and resilience goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.